• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MMY
Click for more information
0.00% 7.0¢

MNET GROUP LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
MMYAppendix 4C - quarterlyPRICE SENSITIVE30/10/09
MMYMerger with m.Net CorporationPRICE SENSITIVE07/09/09
MMYPreliminary Final ReportPRICE SENSITIVE31/08/09
MMYAppendix 4C - quarterlyPRICE SENSITIVE03/07/09
MMYAppendix 4C - quarterlyPRICE SENSITIVE29/04/09
MMYHalf Yearly Report and AccountsPRICE SENSITIVE27/02/09
MMYAppendix 4C - quarterlyPRICE SENSITIVE28/01/09
MMYAppendix 4C - quarterly
30/10/09PRICE SENSITIVE
MMYMerger with m.Net Corporation
07/09/09PRICE SENSITIVE
MMYPreliminary Final Report
31/08/09PRICE SENSITIVE
MMYAppendix 4C - quarterly
03/07/09PRICE SENSITIVE
MMYAppendix 4C - quarterly
29/04/09PRICE SENSITIVE
MMYHalf Yearly Report and Accounts
27/02/09PRICE SENSITIVE
MMYAppendix 4C - quarterly
28/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
HotCopper Highlights: Your most watched stocks for Week 46, 2024 What you - HotCopper users - were most interested in viewing and discussing this week (Week 46 of the year!)
Week 46 Wrap: Copper hits 2mth low as Trump threatens net zero pace; US rally fades; HotCopper’s picks Copper prices slump; Trump Wall Street rally fades; US health stocks dip on RFK appointment – and much more.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.